SCHEMBL4573173

SCHEMBL4573173

CC(=O)/C=C/c1ccnc(C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IAPP P10997 1/20 0.51
PTGS1 P23219 1/20 0.51
GLA P06280 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
FDPS P14324 1/20 0.45
APP P05067 4/20 0.45
HTT P42858 2/20 0.41
GAA P10253 1/20 0.41
UHRF1 Q96T88 1/20 0.41
JUN P05412 1/20 0.40
NFKB1 P19838 1/20 0.40
MAPT P10636 3/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40
NR3C1 P04150 1/20 0.39
PPARG P37231 1/20 0.39
SMARCA2 P51531 1/20 0.37
SMARCA4 P51532 1/20 0.37
LMNA P02545 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4573175 1.00 IAPP (0.51) IAPPPTGS1GLATDP1FDPS
SCHEMBL17053206 1.00 IAPP (0.51) IAPPPTGS1GLATDP1FDPS
SCHEMBL2960999 0.86 KDM4E (0.49) GLATDP1APPGAANFKB1
SCHEMBL2961000 0.86 KDM4E (0.49) GLATDP1APPGAANFKB1
SCHEMBL24150774 0.81 IP6K1 (0.43) PTGS1APPUHRF1JUNNFKB1
SCHEMBL28287607 0.81 TTR (0.55) GLAFDPSAPPHTTGAA
SCHEMBL17053221 0.81 KMT2A (0.51) IAPPPTGS1TDP1GAAUHRF1
SCHEMBL26820204 0.81 IAPP (0.54) IAPPPTGS1GLATDP1FDPS
SCHEMBL25075381 0.81 IAPP (0.54) IAPPPTGS1GLATDP1FDPS
SCHEMBL21633161 0.79 TTR (0.60) FDPSAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080267942-A1 BENZAZEPIN-2(1H)-ONE DERIVATIVES PFIZER LIMITED (GB) 2008-10-30 US disclosed
WO-2008050207-A1 HETEROCYCLIC COMPOUNDS USEFUL AS ANABOLIC AGENTS FOR LIVESTOCK ANIMALS PFIZER LIMITED (GB) 2008-05-02 WO disclosed
US-20080103130-A1 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality PFIZER LIMITED (GB) 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103130-A1 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality ADRB2, ADRB1, ADRA2C IAPP 3425/4885PTGS1 1978/4885GLA 3765/4885
US-20080267942-A1 BENZAZEPIN-2(1H)-ONE DERIVATIVES ADRB2, ADRB1, ADRA2C IAPP 2319/4885PTGS1 1489/4885GLA 1776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.